Section 04 · About GLSG
World-Class Advisors for Your Global Expansion
Abstract
Partner with seasoned bio-pharma executives and clinical leaders who possess a proven track record of driving cross-border success.
4.1 — External Expert
Pascal Borderies, MD
New York: CMO, Clinical Drug Development, Immuno-Oncology
Pascal Borderies, MD, is an accomplished Chief Medical Officer & biopharma executive with a deep expertise in clinical development strategy & execution for early clinical compounds in various therapeutic areas — including but not limited to neurodegenerative diseases, autoimmune diseases, immuno-oncology — discerning the key questions that need to be answered to maximize their value in the marketplace. He has held key leadership roles in small biotechs & global pharmaceutical leaders, including Novartis, Sanofi-Synthélabo, and Schering-Plough.
4.2 — External Expert
Jean-Luc Boulnois, PhD
Boston: Medical Device, Medtech Executive
Dr. Jean-Luc Boulnois is a 38-year medical device industry veteran who scaled global medtech companies like Microline Surgical, currently serving as President & CEO of Quadrature Inc., where he leverages an extensive international healthcare network to provide strategic and operational expertise to early-stage entrepreneurs and mid-market CEOs.
4.3 — External Expert
GiHun Choi, PhD
Boston: Life Sciences Investment, Biotechnology, Translational Research
Dr. GiHun Choi is a life sciences investor and scientist with a strong background in biological engineering and translational research. He earned his PhD from Harvard University after completing his undergraduate studies at MIT, where his research spanned regenerative medicine, systems biology, and biomedical engineering. Drawing on his scientific training and experience in the Boston biotech ecosystem, he evaluates emerging technologies and supports early-stage life sciences companies in translating scientific innovation into commercially viable opportunities.
4.4 — External Expert
Eric Evans
Boston: Investor; Executive Committee, Mass Medical Angels; Senior Fellow, Harvard Kennedy School; Entrepreneur in Residence, University of Massachusetts
Eric Evans is an early-stage investor in life sciences companies with over 24 years of experience in business growth consulting and executive leadership. He serves on the Executive Committee at Mass Medical Angels, where he leads financing rounds and performs due diligence. Throughout his career, he has frequently stepped into leadership roles as an interim CEO or Board member to accelerate early-stage healthcare companies toward advanced development.
4.5 — External Expert
David S. Friedman, MD, PhD, MPH
Boston: Glaucoma Specialist, Clinical Research
David S. Friedman, MD, PhD, MPH is a glaucoma specialist and epidemiologist with over 450 publications and over 25 years of clinical experience. He has had consistent federal grant funding throughout his highly successful career and brings a wealth of knowledge to the team about the conduct of clinical research and the clinical landscape.
4.6 — External Expert
Silvia Helou, MD, PhD, MMSc
New York: Clinical Trial, Medical Device
Dr. Silvia Helou is a global clinical development expert with over 25 years of experience in infectious diseases and multiple therapeutics areas, who has driven multiple successful FDA approvals and global Phase I–IV trials at major pharma leaders like Novartis and Schering-Plough, and currently provides strategic clinical consulting as the Founder of Helou Consulting.
4.7 — External Expert
Kathy Ku, MD, MBA
San Francisco Bay Area: Healthcare Investment, Entrepreneurship, Global Health
Dr. Kathy Ku is a healthcare investor and entrepreneur with a multidisciplinary background spanning medicine, business, engineering, and life sciences. She earned her MD and MBA from Stanford University and holds degrees in Molecular and Cellular Biology and Engineering Sciences from Harvard University. She co-founded SPOUTS of Water, a social enterprise that has provided clean drinking water to more than one million people, and currently invests in healthcare and early-stage companies through Sazze Partners. She brings a unique combination of medical training, entrepreneurial experience, and investment expertise to support healthcare companies in strategy, growth, and commercialization.
4.8 — External Expert
Mac M. Martirossian
Atlanta: Investment Banking, Corporate Finance, M&A Advisory
Mac M. Martirossian is an accomplished business executive and financial strategist with extensive experience in corporate finance, investment banking, and strategic planning. A Certified Public Accountant, he has held senior management roles at The Home Depot and worked as a consultant and auditor with Price Waterhouse. He specializes in mergers and acquisitions, cross-functional leadership, and executive coaching, helping companies scale across international markets.
4.9 — External Expert
Jean-Marie P. Vallet, PhD, M.B.A.
Boston: Investor, Business Executive, Business Development, M&A
Dr. Jean-Marie P. Vallet is a scientist and a business executive with international experience in technology evaluation, business development, and consulting. A former molecular biology engineer (PhD) with 10 years of experience in contract research organizations, he transitioned to business executive roles (after an MBA) in both large pharma and small biotechs across four countries (France, Switzerland, Germany, USA). He focuses on international sales and administration, business development, M&A, and consulting. He also brings 10 years of experience as an angel investor within the Boston innovation ecosystem, supporting and advising early-stage startups.
The experts are listed in alphabetical order.
World-class expertise for cross-border success.
Reach out to GLSG for tailored biotech guidance.